、关注Q3业绩催化，对Q4医药行情保持乐观医药生物-医药生物行业周报证券研究报告/行业周报2023年10月22日评级：增持（维持）[重Ta点bl公e_司Fi基na本nc状e]况分析师：祝嘉琦公司名称股价EPSPEPEG评级执业证书编号：S0740519040001电话：021-2031515020222023E2024E2025E20222023E2024E2025E0.92买入Email：zhujq@zts.com.cn1.72买入分析师：孙宇瑶药明康德84.622.973.E314.215.4028.5025.6020.1115.662.43买入执业证书编号：S07405220600020.360.460.5861.1245.5036.0728.470.76买入Email：sunyy03@zts.com.cn爱尔眼科16.540.271.311.521.7446.9937.3032.1628.020.93买入1.021.381.9237.6028.4220.9515.101.44买入同仁堂48.851.043.063.494.0116.6113.4611.7910.270.70买入0.790.951.1236.7827.3822.9219.340.62买...